Methodology: 1/5          
Usefulness: 1/5

von Dach E, et al. JAMA. 2020 Jun 2;323(21):2160-2169. doi: 10.1001/jama.2020.6348.

Question and Methods: In a multi-center, noninferiority, randomized, double-blinded clinical trial, the authors compared the rates of clinical failure by day 30 on individualized CRP-guided antibiotic durations compared to a fixed 7-day regimen vs a fixed 14-day regimen in patients with GNB.
Findings: 30-day clinical failure rates in the CRP-guided and the 7-day treatment group were non-inferior to the 14-day treatment group (2,4%, 6.6% and 5.5% respectively).  
Limitations: There was a significant loss of patients to follow-up, many patients in each group did not undergo ITT analysis due to deviations from the study protocol, and this was a large European Caucasian population. 

Interpretation: CRP should not be used in the ED to guide antibiotic treatment duration in GNB.

By: Dr. Darren Wong


  • Darren Wong

    Dr. Darren Wong is a FRCPC Emergency Medicine Physician who has an interest in the care of critically ill patients and trauma care.

    View all posts
  • Hans Rosenberg

    Dr. Rosenberg is an emergency physician at the Ottawa Hospital, associate professor at the University of Ottawa, and Director of the Digital Scholarship and Knowledge Dissemination Program.

    View all posts